Harvard Bioscience Schedules Fourth Quarter 2024 Earnings Conference Call for March 12, 2025 at 8:00 AM ET
Portfolio Pulse from
Harvard Bioscience, Inc. (Nasdaq: HBIO) will release its Q4 2024 financial results on March 12, 2025, before the market opens, followed by a conference call at 8:00 AM ET to discuss the results.
February 24, 2025 | 4:15 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Harvard Bioscience will release its Q4 2024 earnings on March 12, 2025, with a conference call scheduled for 8:00 AM ET. This event could impact HBIO's stock price based on the financial results and guidance provided.
The announcement of earnings and the subsequent conference call are significant events for investors as they provide insights into the company's financial health and future outlook. The stock price could be influenced by the results and any forward-looking statements made during the call.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100